Several medications now calm painful inflammation in the intestines. Diets free of ultraprocessed foods also help ...

J&J innovative medicine gastroenterology and autoantibody ... "FDA approves Johnson & Johnson’s Tremfya to treat Crohn’s disease" was originally created and published by Pharmaceutical ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an important role in the disease ...

Dr. Madeline Eckenrode is a med-peds physician serving patients in Birmingham, AL. These views are her own and do not reflect ...

There are many contributing factors to fatigue in Crohn’s disease patients, says Supriya Rao, MD, a quadruple board-certified physician in internal medicine, gastroenterology, obesity medicine ...

Researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, including Alzheimer's disease ...

Johnson & Johnson (J&J) has announced that its Tremfya (guselkumab) has been recommended by the European Medicines Agency’s ...

Learn about enteropathic arthritis, a common extra-intestinal symptom of Crohn’s disease that affects the joints.

Research into two novel approaches to managing and treating Crohn’s disease may lead to dramatic improvements for children ...

Oregon State University researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, ...

“Other indications that have been reported for fecal transplant have been inflammatory bowel disease — that's Crohn's disease and ulcerative ... Maryland School of Medicine in Baltimore. “ ...

The NIMML Institute, ("NIMML"), a 501 (c)(3) nonprofit institute dedicated to the discovery of novel precision medicines for inflammatory and autoimmune diseases, will present results from two novel ...